Literature DB >> 27513319

Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.

Zhong Lin1, Junling Zhao2, Xindan Wang3, Xuehong Zhu2, Liansheng Gong1.   

Abstract

MicroRNAs are a class of endogenous, small non-coding RNAs which are tightly involved in evolution and progression of human cancers. MicroRNA-497 has been reported as tumor-suppressor in various human cancer. However, the role of miR-497 in ovarian cancer is still poorly known. We investigated the expression level and cellular function of miR-497 in human ovarian cancer. In this study, the expression of miR-497 in ovarian cancer tissues and SKOV3 cells was detected by quantitative reverse‑transcription polymerase chain reaction (qRT-PCR). CCK-8 assay was used to analysis the cell proliferation. Transwell assay was performed to analysis cell migration and invasion. Cell apoptosis was evaluated by flow cytometry. Luciferase assay was performed to verify a putative target site of miR-497 in the 3'UTR of PAX2 mRNA. The results showed that miR-497 was markedly decreased in ovarian cancer tissues and SKOV3 cells. Moreover, overexpression of miR-497 in SKOV3 cells induced PAX2 protein expression and resulted in inhibition of cell proliferation, migration and invasion, and induction of cell apoptosis. In addition, we confirmed that PAX2 is a direct target gene of miR-497. Furthermore, Silencing of PAX2 by RNA interference suppressed cell proliferation and promoted cell apoptosis in vitro. Taken together, our study rationally present that miR-497 has a potential role as a useful diagnostic and therapeutic biomarker for human ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27513319     DOI: 10.3892/or.2016.5012

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

Review 1.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

Review 2.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

3.  MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function.

Authors:  Nianqing Wan; Jianxiao Zheng
Journal:  Oncol Lett       Date:  2021-05-02       Impact factor: 2.967

Review 4.  An Analysis of Mechanisms for Cellular Uptake of miRNAs to Enhance Drug Delivery and Efficacy in Cancer Chemoresistance.

Authors:  Justine M Grixti; Duncan Ayers; Philip J R Day
Journal:  Noncoding RNA       Date:  2021-04-16

5.  MicroRNA-663 antagonizes apoptosis antagonizing transcription factor to induce apoptosis in epithelial cells.

Authors:  M R Benakanakere; J Zhao; L Finoti; R Schattner; M Odabas-Yigit; D F Kinane
Journal:  Apoptosis       Date:  2019-02       Impact factor: 5.561

6.  MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.

Authors:  Juhua Zhuang; Ying Ye; Guoyu Wang; Jing Ni; Saifei He; Cuihua Hu; Wei Xia; Zhongwei Lv
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 3.423

7.  Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.

Authors:  Tiphaine de Foucher; Maria Sbeih; Jenifer Uzan; Sofiane Bendifallah; Marine Lefevre; Nathalie Chabbert-Buffet; Selim Aractingi; Catherine Uzan; Issam Abd Alsalam; Rana Mitri; Romain H Fontaine; Emile Daraï; Bassam Haddad; Céline Méhats; Marcos Ballester; Geoffroy Canlorbe; Cyril Touboul
Journal:  J Transl Med       Date:  2018-05-21       Impact factor: 5.531

8.  Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition.

Authors:  Jun Yang; Du He; Yan Peng; Hongzhen Zhong; Yuhong Deng; Zhonghua Yu; Chengnong Guan; Yufang Zuo; Zumin Xu
Journal:  Onco Targets Ther       Date:  2017-10-27       Impact factor: 4.147

9.  miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor.

Authors:  Wei Ma; Weiye Feng; Jie Tan; Airu Xu; Yudong Hu; Lanlan Ning; Yanhong Kang; Liuqian Wang; Ziwen Zhao
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

10.  miR-744-5p Inhibits Non-Small Cell Lung Cancer Proliferation and Invasion by Directly Targeting PAX2.

Authors:  Shaolin Chen; Fei Shi; Weixing Zhang; Yuqi Zhou; Jing Huang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.